Correlation Between Cell Source and DMK Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cell Source and DMK Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cell Source and DMK Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cell Source and DMK Pharmaceuticals, you can compare the effects of market volatilities on Cell Source and DMK Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cell Source with a short position of DMK Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cell Source and DMK Pharmaceuticals.

Diversification Opportunities for Cell Source and DMK Pharmaceuticals

0.0

Correlation Coefficient

Cell Source  DMK Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Cell and DMK is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cell Source and DMK Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DMK Pharmaceuticals and Cell Source is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cell Source are associated (or correlated) with DMK Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DMK Pharmaceuticals has no effect on the direction of Cell Source i.e., Cell Source and DMK Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cell Source and DMK Pharmaceuticals

If you would invest  30.00  in Cell Source on April 29, 2025 and sell it today you would earn a total of  10.00  from holding Cell Source or generate 33.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Cell Source  vs.  DMK Pharmaceuticals

Cell Source

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cell Source are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, Cell Source unveiled solid returns over the last few months and may actually be approaching a breakup point.

DMK Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days DMK Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, DMK Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Cell Source and DMK Pharmaceuticals

The main advantage of trading using opposite Cell Source and DMK Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cell Source position performs unexpectedly, DMK Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DMK Pharmaceuticals will offset losses from the drop in DMK Pharmaceuticals' long position.

The idea behind Cell Source and DMK Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.